MedTrace Logo

Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer

NCT02316561 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2018-07-20

No results posted yet for this study

Summary

The purpose of the study is to investigate the feasibility of a preoperative, single dose, ablative partial breast radiation treatment in patients with early-stage breast cancer.

Conditions

  • Breast Neoplasm

Interventions

RADIATION

Single dose ablative radiotherapy

A single dose ablative radiotherapy will be delivered prior to surgery

Sponsors & Collaborators

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • HJGD van den Bongard, MD, PhD · UMC Utrecht

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02316561 on ClinicalTrials.gov